Detection of indinavir crystals in urine: Dependence on method of analysis

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 2, 2000, Pages 246-250

  Hortin, Glen L ^a,c   King, Christine ^a   Miller, Kirk D ^a   Kopp, Jeffrey B ^b  

^a Warren Grant Magnusson Clin Center   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE INHIBITOR;

ARTICLE; AUTOANALYZER; CONTROLLED STUDY; CRYSTAL; CRYSTALLURIA; DIAGNOSTIC PROCEDURE; HEMOGLOBINURIA; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MICROSCOPY; PROTEINURIA; RELATIVE DENSITY; URINALYSIS; URINE PH;

CRYSTALLIZATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDINAVIR; MICROSCOPY, POLARIZATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 0033950317     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep. 1998;47:40-82.
2. Deeks SG, Smith M, Holodniy M. HIV-1 protease inhibitors. JAMA. 1997;277:145-153.
3. Balani SK, Ariso BH, Mathai L. Metabolites of L735,524, a potent HIV-1 protease inhibitor, in human urine. Drug Metab Dispos. 1995;23:266-270.
4. Lin JH, Chen I-W, Vastag KJ, et al. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs. Drug Metab Dispos. 1995;23:730-735.
5. Sutherland SE, Reigle MD, Seftel AD, Resnick MI. Protease inhibitors and urolithiasis. J Urol. 1997;158:31-33.
6. Ascher DP, Lucy MD. Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection. Ann Pharmacother. 1997;31:1146-1149.
7. Bruce RG, Munch LC, Hoven AD, et al. Urolithiasis associated with the protease inhibitor indinavir. Urology. 1997;50:513-518.
8. Grunke M, Valerius T, Manger B, Kalden JR, Harrer T. Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir. Clin Infect Dis. 1997;25:1270-1271.
9. Rich JD, Ramratnam B, Chiang M, Tashima KT. Management of indinavir associated nephrolithiasis. J Urol. 1997;158:2228.
10. Chen SC, Nankivell BJ, Dwyer DE. Indinavir-induced renal failure [letter]. AIDS. 1998;12:440-441.
11. Martinez F, Mommeja-Marin H, Estepa-Maurice L, et al. Indinavir crystal deposits associated with tubulointerstitial nephropathy. Nephrol Dial Transplant. 1998;13:750-753.
12. Lerner LB, Cendron M, Rous SN. Nephrolithiasis from indinavir, a new human immunodeficiency virus drug. J Urol. 1998;159:2074.